Treating Breast Cancer

Here are some recent news (September 06) on how to treat breast cancer:
Testing and research on how to treat diseases are not limited to North America. A researcher at the University of Edinburgh has developed new procedures for analyzing affecting radiotherapy after surgery for breast cancer. New procedures can help doctors determine who would benefit from receiving radiation therapy as a follow up to surgery. These new techniques will require physicians to test tissue samples from breast cancer surgery to decide who should also receive radiotherapy.

A new test should be done at international level will follow 3700 women to observe the benefits of radiotherapy in women with medium risk of reoffending. The study will also follow this group of women to discover if there is a considerable risk of damage as a basis for those who underwent therapy for the announcement. In short, it is important to determine if radiation has a significant impact on cancer recurrence in patients at low risk of cancer.

The trial will seek to identify a novel molecular signature of breast cancer that may help decide if radiotherapy is necessary to prevent recurrence. Tissue from breast cancer surgery will be used for further study in the future. Scientists are concerned about the long-term effect upon the heart of the issue and chemotherapy. The brain natriuretic peptide protein also being investigated to see if it is an early sign of cardiac damage. Electrocardiography and echocardiography will also be used to identify the signs of premature heart disease.

This study attempts also want to consider the quality of life for survivors of breast cancer. They will examine the impact of the issuance and chemotherapy for breast reconstruction and quality of other aspects of life. It will include women from around the world. More than 120 breast cancer centers in the world have already registered to participate in this project.

The study could have an impact on the cost of treating breast cancer. If we can determine if radiotherapy does not increase the survival rate of patients who are at low risk, it could save the medical community and patients of thousands of dollars. It is important to remember that the health and survival of patients are the main concern of any testing or research conducted throughout the world.
Research can determine whether women who were considered at low risk of recurrence of breast cancer could benefit from radiotherapy.

This new international trial is sponsored and funded by the University of Edinburgh and Lothian Health Board and the United Kingdom Medical Research Council. The European Organization for Research and Treatment of Cancer and the Breast International Group will coordinate the efforts of tests in the world.